Precigen (PGEN)
Precigen on one page: short interest, daily short volume, fails to deliver, planned sales, large holders, 13F holders, financials, earnings dates and insider trades. Listed on Nasdaq, classified by the SEC as pharmaceutical preparations.
46.4M
Short interest
settlement 2026-10-15
10.2
Days to cover
+2.8 days vs prior
65.2%
Short share of volume
2026-11-02
309
Fails to deliver
settlement 2026-09-30
Thu 12 Nov
Next earnings
estimated date
-$2.5M
Insider flow, 90 days
1 buys, 5 sells
As of 2026-11-02.
Short interest
FINRA, twice a month. The newest 48 settlements in the table, 48 in the chart. JSONAs of 15 October 2026, short interest in PGEN is 46,390,144 shares, up 4,111,907 shares over the last month. Over the last 48 readings it ranged from 15,321,505 shares (31 October 2024) to 47,547,517 shares (30 September 2026). The latest reading sits at the top of that range. At the reported average volume of 4.5M shares a day that is 10.2 days to cover.
Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/pgen" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-10-15 | 46,390,144 | -2.4% | 4,542,276 | 10.21 |
| 2026-09-30 | 47,547,517 | +12.5% | 6,444,570 | 7.38 |
| 2026-09-15 | 42,278,237 | +0.2% | 2,598,893 | 16.27 |
| 2026-08-31 | 42,180,337 | -0.1% | 5,332,363 | 7.91 |
| 2026-08-14 | 42,240,157 | +0.5% | 7,214,381 | 5.85 |
| 2026-07-31 | 42,044,362 | +2.5% | 3,779,683 | 11.12 |
| 2026-07-15 | 41,025,860 | -7.2% | 4,263,642 | 9.62 |
| 2026-06-30 | 44,222,506 | +2.0% | 5,810,243 | 7.61 |
| 2026-06-15 | 43,338,122 | +7.7% | 5,866,310 | 7.39 |
| 2026-05-29 | 40,254,841 | +1.0% | 4,211,529 | 9.56 |
| 2026-05-15 | 39,871,277 | +0.3% | 3,607,150 | 11.05 |
| 2026-04-30 | 39,770,522 | -0.1% | 2,741,211 | 14.51 |
| 2026-04-15 | 39,794,906 | +0.3% | 3,696,445 | 10.77 |
| 2026-03-31 | 39,661,787 | -0.3% | 7,056,277 | 5.62 |
| 2026-03-13 | 39,788,994 | -5.0% | 3,750,344 | 10.61 |
| 2026-02-27 | 41,882,137 | +1.9% | 5,551,482 | 7.54 |
| 2026-02-13 | 41,094,402 | -2.1% | 3,195,930 | 12.86 |
| 2026-01-30 | 41,975,778 | +6.5% | 3,597,567 | 11.67 |
| 2026-01-15 | 39,413,898 | +10.8% | 3,919,262 | 10.06 |
| 2025-12-31 | 35,580,646 | +28.2% | 6,911,562 | 5.15 |
| 2025-12-15 | 27,758,985 | -5.7% | 2,830,423 | 9.81 |
| 2025-11-28 | 29,435,025 | +1.9% | 4,347,190 | 6.77 |
| 2025-11-14 | 28,884,978 | -15.9% | 4,993,411 | 5.78 |
| 2025-10-31 | 34,330,841 | +7.1% | 4,599,181 | 7.46 |
| 2025-10-15 | 32,041,619 | -15.1% | 4,865,988 | 6.58 |
| 2025-09-30 | 37,754,111 | +6.8% | 6,706,855 | 5.63 |
| 2025-09-15 | 35,351,601 | -2.2% | 6,506,171 | 5.43 |
| 2025-08-29 | 36,134,649 | +16.9% | 14,367,576 | 2.52 |
| 2025-08-15 | 30,907,663 | +7.2% | 18,352,944 | 1.68 |
| 2025-07-31 | 28,833,129 | +1.4% | 3,357,521 | 8.59 |
| 2025-07-15 | 28,429,094 | -2.1% | 2,600,111 | 10.93 |
| 2025-06-30 | 29,034,954 | +6.4% | 2,043,978 | 14.21 |
| 2025-06-13 | 27,281,305 | -1.3% | 1,563,747 | 17.45 |
| 2025-05-30 | 27,625,665 | -3.9% | 1,713,044 | 16.13 |
| 2025-05-15 | 28,738,310 | +3.7% | 1,730,848 | 16.60 |
| 2025-04-30 | 27,703,794 | +9.3% | 1,176,430 | 23.55 |
| 2025-04-15 | 25,355,481 | +6.1% | 1,548,882 | 16.37 |
| 2025-03-31 | 23,904,722 | +5.5% | 1,416,050 | 16.88 |
| 2025-03-14 | 22,657,367 | +5.0% | 1,247,326 | 18.16 |
| 2025-02-28 | 21,571,396 | +13.2% | 2,291,171 | 9.42 |
| 2025-02-14 | 19,049,259 | +0.1% | 2,525,184 | 7.54 |
| 2025-01-31 | 19,037,437 | +0.9% | 1,686,707 | 11.29 |
| 2025-01-15 | 18,858,399 | +8.1% | 2,442,173 | 7.72 |
| 2024-12-31 | 17,452,103 | -2.4% | 2,204,571 | 7.92 |
| 2024-12-13 | 17,880,545 | +5.5% | 994,604 | 17.98 |
| 2024-11-29 | 16,944,286 | +4.8% | 871,423 | 19.44 |
| 2024-11-15 | 16,173,678 | +5.6% | 969,759 | 16.68 |
| 2024-10-31 | 15,321,505 | -0.3% | 578,356 | 26.49 |
Daily short volume
FINRA Reg SHO, the last 30 sessions. JSONAs of 2 November 2026, the short share of PGEN volume is 65.2%, up 11.9 points over the last five sessions. Over the last 30 readings it ranged from 28.8% (15 October 2026) to 72.7% (20 October 2026). The latest reading is 16.8 points above the 30-session average of 48.3%, on 8.0M shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-11-02 | 5.2M | 8.0M | 65.2% | 504,916 |
| 2026-10-30 | 1.6M | 2.6M | 64.0% | 43,710 |
| 2026-10-29 | 1.7M | 3.3M | 50.2% | 3,341 |
| 2026-10-28 | 604K | 1.5M | 40.3% | 2,146 |
| 2026-10-27 | 677K | 1.6M | 41.7% | 2,114 |
| 2026-10-26 | 566K | 1.1M | 53.3% | 0 |
| 2026-10-23 | 1.3M | 1.9M | 68.4% | 7,838 |
| 2026-10-22 | 1.6M | 2.3M | 70.3% | 802 |
| 2026-10-21 | 1.8M | 2.6M | 66.4% | 0 |
| 2026-10-20 | 1.8M | 2.5M | 72.7% | 0 |
| 2026-10-19 | 733K | 1.9M | 39.1% | 63,031 |
| 2026-10-16 | 583K | 2.0M | 29.5% | 34,348 |
| 2026-10-15 | 490K | 1.7M | 28.8% | 29 |
| 2026-10-14 | 655K | 1.7M | 38.8% | 27,163 |
| 2026-10-13 | 283K | 679K | 41.8% | 10,714 |
| 2026-10-12 | 374K | 842K | 44.4% | 1,079 |
| 2026-10-09 | 620K | 1.3M | 46.9% | 615 |
| 2026-10-08 | 553K | 1.1M | 48.3% | 5,027 |
| 2026-10-07 | 520K | 1.1M | 46.4% | 2,964 |
| 2026-10-06 | 778K | 2.2M | 34.9% | 74,607 |
| 2026-10-05 | 1.7M | 3.7M | 44.8% | 114,885 |
| 2026-10-02 | 2.0M | 3.0M | 64.6% | 3,642 |
| 2026-10-01 | 583K | 1.7M | 34.9% | 3,382 |
| 2026-09-30 | 1.6M | 5.3M | 29.9% | 19,843 |
| 2026-09-29 | 686K | 1.4M | 47.7% | 1,375 |
| 2026-09-28 | 410K | 1.1M | 37.5% | 0 |
| 2026-09-25 | 1.1M | 2.3M | 49.2% | 16,954 |
| 2026-09-24 | 1.3M | 1.8M | 71.5% | 300 |
| 2026-09-23 | 1.0M | 2.2M | 47.6% | 0 |
| 2026-09-22 | 606K | 2.0M | 30.2% | 114 |
Fails to deliver
SEC, the last 30 settlement dates with a fail. JSONAs of 30 September 2026, the fails-to-deliver balance in PGEN is 309 shares, up 163 shares over the last settlement date. Over the last 30 readings it ranged from 4 shares (31 August 2026) to 126,584 shares (30 July 2026). The latest reading sits at the bottom of that range.
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-09-30 | 309 | $8.05 | $2K |
| 2026-09-29 | 146 | $7.81 | $1K |
| 2026-09-28 | 2,945 | $7.75 | $23K |
| 2026-09-25 | 2,962 | $7.70 | $23K |
| 2026-09-23 | 31 | $7.89 | $245 |
| 2026-08-31 | 4 | $6.95 | $28 |
| 2026-08-28 | 113,406 | $7.19 | $815K |
| 2026-08-24 | 1,991 | $7.20 | $14K |
| 2026-08-19 | 64 | $6.75 | $432 |
| 2026-08-18 | 8,666 | $6.55 | $57K |
| 2026-08-14 | 1,295 | $6.49 | $8K |
| 2026-08-11 | 224 | $7.00 | $2K |
| 2026-08-04 | 1,711 | $6.61 | $11K |
| 2026-08-03 | 247 | $6.27 | $2K |
| 2026-07-30 | 126,584 | $5.45 | $690K |
| 2026-07-22 | 2,000 | $5.49 | $11K |
| 2026-07-17 | 299 | $4.95 | $1K |
| 2026-07-16 | 4,537 | $5.12 | $23K |
| 2026-07-15 | 4,249 | $5.12 | $22K |
| 2026-07-10 | 10,000 | $5.53 | $55K |
| 2026-07-06 | 1,214 | $5.64 | $7K |
| 2026-06-30 | 57,490 | $5.92 | $340K |
| 2026-06-25 | 984 | $5.40 | $5K |
| 2026-06-22 | 108 | $4.82 | $521 |
| 2026-06-15 | 3,748 | $4.45 | $17K |
| 2026-06-11 | 1,925 | $3.89 | $7K |
| 2026-06-10 | 1,942 | $3.71 | $7K |
| 2026-06-08 | 7 | $3.58 | $25 |
| 2026-06-03 | 10,133 | $3.86 | $39K |
| 2026-05-29 | 14,383 | $4.51 | $65K |
Insider trades
SEC Form 4, newest first. JSONOver the last 90 days PGEN insiders reported 1 open-market buy ($25K) against 5 sells ($2.6M), so the dollar flow leans toward selling. Latest filing: Thomasian Harry Jr. (Chief Financial Officer) on 2026-09-23.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-09-23 | Thomasian Harry Jr. | Chief Financial Officer | Exercise or conversion | 1 | $1.21 | $1 | 312K |
| 2026-09-23 | Thomasian Harry Jr. | Chief Financial Officer | Exercise or conversion | 2 | $0.96 | $2 | 312K |
| 2026-09-23 | Thomasian Harry Jr. | Chief Financial Officer | Exercise or conversion | 43K | $2.33 | $100K | 312K |
| 2026-09-23 | Thomasian Harry Jr. | Chief Financial Officer | Exercise or conversion | 11K | $4.72 | $51K | 269K |
| 2026-08-26 | KINDLER JEFFREY B | Director | Sell | 185K | $7.44 | $1.4M | 17K |
| 2026-08-25 | Tennant Phil | Chief Commercial Officer | Sell | 79K | $7.50 | $594K | 142K |
| 2026-08-25 | Tennant Phil | Chief Commercial Officer | Exercise or conversion | 79K | $1.61 | $127K | 221K |
| 2026-08-25 | Shah Rutul R | Chief Operating Officer | Sell | 15K | $7.50 | $115K | 469K |
| 2026-08-25 | Shah Rutul R | Chief Operating Officer | Exercise or conversion | 15K | $2.33 | $36K | 484K |
| 2026-08-23 | Sabzevari Helen | President and CEO | Tax withholding | 10K | $7.20 | $73K | 3.8M |
| 2026-08-23 | Sabzevari Helen | President and CEO | Exercise or conversion | 21K | price not stated in the filing | not stated | 3.8M |
| 2026-08-23 | Tennant Phil | Chief Commercial Officer | Tax withholding | 3K | $7.20 | $19K | 142K |
| 2026-08-23 | Tennant Phil | Chief Commercial Officer | Exercise or conversion | 5K | price not stated in the filing | not stated | 145K |
| 2026-08-23 | Shah Rutul R | Chief Operating Officer | Tax withholding | 4K | $7.20 | $26K | 469K |
| 2026-08-23 | Shah Rutul R | Chief Operating Officer | Exercise or conversion | 8K | price not stated in the filing | not stated | 473K |
| 2026-08-23 | Thomasian Harry Jr. | Chief Financial Officer | Tax withholding | 4K | $7.20 | $26K | 258K |
| 2026-08-23 | Thomasian Harry Jr. | Chief Financial Officer | Exercise or conversion | 7K | price not stated in the filing | not stated | 262K |
| 2026-08-23 | Lehr Donald P. | Chief Legal Officer | Tax withholding | 2K | $7.20 | $18K | 758K |
| 2026-08-23 | Lehr Donald P. | Chief Legal Officer | Exercise or conversion | 5K | price not stated in the filing | not stated | 761K |
| 2026-08-21 | Shah Rutul R | Chief Operating Officer | Sell | 35K | $7.50 | $260K | 465K |
| 2026-08-21 | Shah Rutul R | Chief Operating Officer | Exercise or conversion | 35K | $2.33 | $81K | 500K |
| 2026-08-21 | AGEE NANCY H | Director | Buy | 3K | $7.23 | $25K | 309K |
| 2026-08-06 | Shah Rutul R | Chief Operating Officer | Sell | 33K | $6.86 | $225K | 465K |
| 2026-08-03 | Shah Rutul R | Chief Operating Officer | Sell | 34K | $6.50 | $220K | 498K |
| 2026-08-03 | Shah Rutul R | Chief Operating Officer | Exercise or conversion | 34K | $2.33 | $79K | 532K |
| 2026-07-31 | Thomasian Harry Jr. | Chief Financial Officer | Sell | 100K | $6.06 | $606K | 255K |
| 2026-07-01 | Thomasian Harry Jr. | Chief Financial Officer | Sell | 171K | $5.53 | $948K | 355K |
| 2026-06-29 | Thomasian Harry Jr. | Chief Financial Officer | Sell | 29K | $5.78 | $165K | 526K |
| 2026-06-29 | Shah Rutul R | Chief Operating Officer | Sell | 43K | $5.85 | $251K | 498K |
| 2026-06-29 | Shah Rutul R | Chief Operating Officer | Exercise or conversion | 43K | $2.33 | $100K | 541K |
| 2026-06-29 | Sabzevari Helen | President and CEO | Sell | 347K | $5.89 | $2.0M | 3.8M |
| 2026-06-29 | Sabzevari Helen | President and CEO | Exercise or conversion | 347K | $2.33 | $808K | 4.1M |
| 2026-05-28 | Thomasian Harry Jr. | Chief Financial Officer | Sell | 42K | $4.36 | $183K | 555K |
| 2026-05-28 | Tennant Phil | Chief Commercial Officer | Sell | 30K | $4.36 | $132K | 139K |
| 2026-05-28 | Shah Rutul R | Chief Operating Officer | Sell | 43K | $4.36 | $186K | 498K |
| 2026-05-28 | Sabzevari Helen | President and CEO | Sell | 119K | $4.36 | $520K | 3.8M |
| 2026-05-28 | Lehr Donald P. | Chief Legal Officer | Sell | 29K | $4.36 | $127K | 755K |
| 2026-05-23 | Lehr Donald P. | Chief Legal Officer | Exercise or conversion | 63K | price not stated in the filing | not stated | 785K |
| 2026-05-23 | Sabzevari Helen | President and CEO | Exercise or conversion | 250K | price not stated in the filing | not stated | 3.9M |
| 2026-05-23 | Shah Rutul R | Chief Operating Officer | Exercise or conversion | 90K | price not stated in the filing | not stated | 540K |
| 2026-05-23 | Tennant Phil | Chief Commercial Officer | Exercise or conversion | 63K | price not stated in the filing | not stated | 170K |
| 2026-05-23 | Thomasian Harry Jr. | Chief Financial Officer | Exercise or conversion | 88K | price not stated in the filing | not stated | 596K |
| 2026-03-30 | KIRK RANDAL J | Director, 10% owner | Sell | 51K | $3.30 | $168K | 426K |
| 2026-03-30 | KIRK RANDAL J | Director, 10% owner | Sell | 2.3M | $3.30 | $7.7M | 12.3M |
| 2026-03-30 | KIRK RANDAL J | Director, 10% owner | Sell | 24K | $3.30 | $79K | 424K |
| 2026-03-30 | KIRK RANDAL J | Director, 10% owner | Sell | 39K | $3.30 | $129K | 302K |
| 2026-03-30 | KIRK RANDAL J | Director, 10% owner | Sell | 47K | $3.30 | $155K | 519K |
| 2026-03-30 | KIRK RANDAL J | Director, 10% owner | Sell | 169K | $3.30 | $557K | 1.4M |
| 2026-03-30 | KIRK RANDAL J | Director, 10% owner | Sell | 426K | $3.30 | $1.4M | 3.4M |
| 2026-03-30 | KIRK RANDAL J | Director, 10% owner | Sell | 152K | $3.30 | $502K | 1.5M |
| 2026-03-30 | KIRK RANDAL J | Director, 10% owner | Sell | 371K | $3.30 | $1.2M | 3.2M |
| 2026-03-30 | KIRK RANDAL J | Director, 10% owner | Sell | 51K | $3.30 | $168K | 427K |
| 2026-03-30 | KIRK RANDAL J | Director, 10% owner | Sell | 1.1M | $3.30 | $3.7M | 80.7M |
| 2026-03-18 | Lehr Donald P. | Chief Legal Officer | Exercise or conversion | 40K | price not stated in the filing | not stated | 722K |
| 2026-03-18 | Shah Rutul R | Chief Operating Officer | Exercise or conversion | 44K | price not stated in the filing | not stated | 450K |
| 2026-03-18 | Sabzevari Helen | President and CEO | Exercise or conversion | 321K | price not stated in the filing | not stated | 3.6M |
| 2026-03-18 | Tennant Phil | Chief Commercial Officer | Exercise or conversion | 42K | price not stated in the filing | not stated | 107K |
| 2026-03-18 | Thomasian Harry Jr. | Chief Financial Officer | Exercise or conversion | 40K | price not stated in the filing | not stated | 509K |
| 2026-03-13 | Turley James S | Director | Exercise or conversion | 72K | price not stated in the filing | not stated | 685K |
| 2026-03-13 | KINDLER JEFFREY B | Director | Exercise or conversion | 72K | price not stated in the filing | not stated | 202K |
| 2026-03-13 | Hassan Fred | Director | Exercise or conversion | 72K | price not stated in the filing | not stated | 1.2M |
| 2026-03-13 | Gupta Vinita D | Director | Exercise or conversion | 72K | price not stated in the filing | not stated | 666K |
| 2026-03-13 | Frank Steven | Director | Exercise or conversion | 72K | price not stated in the filing | not stated | 1.2M |
| 2026-03-13 | ALVAREZ CESAR L | Director | Exercise or conversion | 72K | price not stated in the filing | not stated | 783K |
| 2026-03-13 | AGEE NANCY H | Director | Exercise or conversion | 72K | price not stated in the filing | not stated | 306K |
| 2026-03-13 | KIRK RANDAL J | Director, 10% owner | Exercise or conversion | 144K | $0.00 | $0 | 81.8M |
| 2026-03-10 | Turley James S | Director | Grant | 18K | $3.51 | $62K | 614K |
| 2026-03-10 | KIRK RANDAL J | Director, 10% owner | Grant | 28K | $3.51 | $100K | 81.6M |
| 2026-03-10 | KINDLER JEFFREY B | Director | Grant | 20K | $3.51 | $69K | 130K |
| 2026-03-10 | Hassan Fred | Director | Grant | 18K | $3.51 | $63K | 1.2M |
| 2026-03-10 | Gupta Vinita D | Director | Grant | 18K | $3.51 | $63K | 594K |
| 2026-03-10 | Frank Steven | Director | Grant | 14K | $3.51 | $50K | 1.2M |
| 2026-03-10 | ALVAREZ CESAR L | Director | Grant | 18K | $3.51 | $62K | 711K |
| 2026-03-10 | AGEE NANCY H | Director | Grant | 16K | $3.51 | $56K | 234K |
| 2025-12-22 | KIRK RANDAL J | Director, 10% owner | Sell | 13K | $4.18 | $54K | 477K |
| 2025-12-22 | KIRK RANDAL J | Director, 10% owner | Sell | 956K | $4.18 | $4.0M | 4.6M |
| 2025-12-22 | KIRK RANDAL J | Director, 10% owner | Sell | 6K | $4.18 | $25K | 448K |
| 2025-12-22 | KIRK RANDAL J | Director, 10% owner | Sell | 10K | $4.18 | $42K | 341K |
| 2025-12-22 | KIRK RANDAL J | Director, 10% owner | Sell | 12K | $4.18 | $50K | 566K |
| 2025-12-22 | KIRK RANDAL J | Director, 10% owner | Sell | 43K | $4.18 | $178K | 1.6M |
| 2025-12-22 | KIRK RANDAL J | Director, 10% owner | Sell | 159K | $4.18 | $666K | 3.8M |
| 2025-12-22 | KIRK RANDAL J | Director, 10% owner | Sell | 39K | $4.18 | $162K | 1.6M |
| 2025-12-22 | KIRK RANDAL J | Director, 10% owner | Sell | 94K | $4.18 | $394K | 3.6M |
| 2025-12-22 | KIRK RANDAL J | Director, 10% owner | Sell | 13K | $4.18 | $54K | 477K |
| 2025-12-22 | KIRK RANDAL J | Director, 10% owner | Sell | 555K | $4.18 | $2.3M | 81.6M |
| 2025-12-12 | KINDLER JEFFREY B | Director | Sell | 235K | $3.63 | $856K | 111K |
| 2025-11-21 | KIRK RANDAL J | Director, 10% owner | Sell | 937K | $3.83 | $3.6M | 5.6M |
| 2025-11-20 | KIRK RANDAL J | Director, 10% owner | Sell | 943K | $4.08 | $3.8M | 6.5M |
| 2025-11-19 | KIRK RANDAL J | Director, 10% owner | Sell | 1.1M | $4.47 | $4.9M | 7.4M |
| 2025-09-30 | KIRK RANDAL J | Director, 10% owner | Sell | 1.8M | $3.41 | $6.2M | 14.6M |
| 2025-09-30 | KINDLER JEFFREY B | Director | Sell | 107K | $3.38 | $361K | 346K |
| 2025-09-29 | Tennant Phil | Chief Commercial Officer | Buy | 6K | $3.58 | $21K | 65K |
| 2025-09-29 | KINDLER JEFFREY B | Director | Sell | 68K | $3.60 | $243K | 453K |
| 2025-09-26 | Thomasian Harry Jr. | Chief Financial Officer | Buy | 3K | $3.42 | $10K | 469K |
| 2025-09-26 | Shah Rutul R | Chief Operating Officer | Buy | 2K | $3.40 | $7K | 406K |
| 2025-09-25 | Thomasian Harry Jr. | Chief Financial Officer | Buy | 8K | $3.62 | $30K | 466K |
| 2025-09-19 | KIRK RANDAL J | Director,TenPercentOwner | Sell | 3.6M | $3.68 | $13.2M | 8.5M |
| 2025-09-18 | KIRK RANDAL J | Director,TenPercentOwner | Sell | 1.4M | $3.86 | $5.4M | 12.1M |
| 2025-09-17 | KIRK RANDAL J | Director,TenPercentOwner | Exercise or conversion | 17.4M | price not stated in the filing | not stated | 82.2M |
| 2025-09-04 | AGEE NANCY H | Director | Buy | 15K | $4.60 | $69K | 218K |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.
Planned sales (Form 144)
Newest first. JSON18 Form 144 notices on file for PGEN worth $70.4M at the prices reported; 4 in the last 90 days worth $1.2M. Latest: Shah Rutul R filed on 2026-08-25 to sell 15,342 shares ($115K) from 2026-08-25.
| Filed | Seller | Shares | Market value | Of outstanding | Sale from | Broker |
|---|---|---|---|---|---|---|
| 2026-08-25 | Shah Rutul ROfficer | 15K | $115K | 0.004% | 2026-08-25 | Fidelity Brokerage Services LLC |
| 2026-08-25 | Tennant PhilOfficer | 79K | $594K | 0.022% | 2026-08-25 | Fidelity Brokerage Services LLC |
| 2026-08-21 | Shah Rutul ROfficer | 35K | $260K | 0.010% | 2026-08-21 | Fidelity Brokerage Services LLC |
| 2026-08-06 | Shah Rutul ROfficer | 33K | $225K | 0.009% | 2026-08-06 | Fidelity Brokerage Services LLC |
| 2026-08-03 | Shah Rutul ROfficer | 34K | $220K | 0.009% | 2026-08-03 | Fidelity Brokerage Services LLC |
| 2026-07-31 | Thomasian Harry Jr.Officer | 100K | $606K | 0.028% | 2026-07-31 | Fidelity Brokerage Services LLC |
| 2026-07-01 | Thomasian Harry Jr.Officer | 171K | $949K | 0.048% | 2026-07-01 | Fidelity Brokerage Services LLC |
| 2026-06-29 | Sabzevari HelenOfficer, Director | 347K | $2.0M | 0.097% | 2026-06-29 | Fidelity Brokerage Services LLC |
| 2026-06-29 | Shah Rutul ROfficer | 43K | $251K | 0.012% | 2026-06-29 | Fidelity Brokerage Services LLC |
| 2026-06-29 | Thomasian Harry Jr.Officer | 29K | $165K | 0.008% | 2026-06-29 | Fidelity Brokerage Services LLC |
| 2026-03-30 | Randal J. KirkDirector, 10% Shareholder | 4.8M | $17.5M | 1.349% | 2026-03-30 | J.P. Morgan Securities LLC |
| 2025-12-22 | Randal J. KirkDirector, 10% Shareholder | 1.9M | $8.2M | 0.537% | 2025-12-22 | J.P. Morgan Securities LLC |
| 2025-11-20 | KIRK RANDAL JDirector, 10% Stockholder | 1.1M | $4.6M | 0.307% | 2025-11-19 | Charles Schwab Corp |
| 2025-11-20 | KIRK RANDAL JDirector, 10% Stockholder | 943K | $3.8M | 0.266% | 2025-11-20 | Charles Schwab Corp |
| 2025-11-19 | KIRK RANDAL JDirector, 10% Stockholder | 1.1M | $4.6M | 0.307% | 2025-11-19 | Charles Schwab Corp |
| 2025-09-30 | KIRK RANDAL JDirector, 10% Stockholder | 1.8M | $6.6M | 0.607% | 2025-09-30 | Charles Schwab Corporation |
| 2025-09-19 | KIRK RANDAL JDirector, 10% Stockholder | 252 | $970 | 0.000% | 2025-09-19 | Charles Schwab Corp |
| 2025-09-18 | KIRK RANDAL JDirector, 10% Stockholder | 5.0M | $19.6M | 1.678% | 2025-09-18 | Charles Schwab Corp |
Large holders (13D and 13G)
One row per reporting person with its latest filing, newest first. JSON6 holders report 5% or more of PGEN in their latest filing, 3 on Schedule 13D (active intent). The largest reported stake is RANDAL J. KIRK at 35.9% of the class (133,956,416 shares), filed 2026-03-31 for an event on 2026-03-30.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-08-07 | 13G/Ano. 6 | Ares Trading SAcorporation | 17.5M | 4.9% | 2026-06-09 |
| 2026-08-07 | 13G/Ano. 6 | Merck Serono SA, Aubonne, Switzerland, an affiliate of Merck KGaA, Darmstadtcorporation | 17.5M | 4.9% | 2026-06-09 |
| 2026-08-07 | 13G/Ano. 6 | Merck KGaA, Darmstadt, Germanycorporation | 17.5M | 4.9% | 2026-06-09 |
| 2026-08-07 | 13G/Ano. 6 | E. Merck KG, Darmstadt Germanycorporation | 17.5M | 4.9% | 2026-06-09 |
| 2026-05-15 | 13G/Ano. 1 | Steven A. Cohenindividual | 6.7M | 1.9% | 2026-03-31 |
| 2026-05-15 | 13G/Ano. 1 | Point72 Capital Advisors, Inc.corporation | 6.7M | 1.9% | 2026-03-31 |
| 2026-05-15 | 13G/Ano. 1 | Point72 Asset Management, L.P.partnership | 6.7M | 1.9% | 2026-03-31 |
| 2026-03-31 | 13D/Ano. 22 | RANDAL J. KIRKindividual | 134.0M | 35.9% | 2026-03-30 |
| 2026-03-31 | 13D/Ano. 22 | R.J. KIRK DECLARATION OF TRUSTother entity | 97.3M | 26.1% | 2026-03-30 |
| 2026-03-31 | 13D/Ano. 22 | THIRD SECURITY, LLCother entity | 21.8M | 5.9% | 2026-03-30 |
| 2026-02-13 | 13G/Ano. 4 | Patient Capital Management, LLCinvestment adviser | 36.0M | 10.2% | 2025-12-31 |
| 2026-02-13 | 13G/Ano. 4 | Patient Opportunity Trust, a Series of Advisor Managed Portfoliosinvestment company | 27.6M | 7.8% | 2025-12-31 |
| 2025-09-23 | 13G | William H. Miller III Living Trust dated April 17, 2017other entity | 34.1M | 9.2% | 2025-06-26 |
| 2025-09-19 | 13D/Ano. 20 | SUNSET 2020 LLCother entity | 16.4M | 4.4% | 2025-09-17 |
13F holders
Tracked managers holding PGEN at their latest 13F. JSON6 of the 30 tracked managers held PGEN at their latest 13F, $17.5M in total at quarter-end prices. Point72 Asset Management is the largest at $7.2M (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 3 added shares and 3 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| Point72 Asset Management | 2026-06-30 | 1.3M | $7.2M | 0.01% | -5.4M |
| Citadel Advisors | 2026-06-30 | 820K | $4.7M | 0.00% | -1.9M |
| Renaissance Technologies | 2026-06-30 | 605K | $3.5M | 0.00% | new |
| AQR Capital Management | 2026-06-30 | 146K | $830K | 0.00% | -39K |
| Two Sigma Investments | 2026-06-30 | 137K | $781K | 0.00% | +64K |
| Millennium Management | 2026-06-30 | 101K | $575K | 0.00% | +41K |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
Financials
SEC XBRL, as filed. JSONIn Q2 FY 2026 (quarter ended 2026-06-30) Precigen reported revenue of $55.0M, up 6322.7% from the same quarter a year earlier, and net income of $20.1M (0.05 diluted EPS). In FY 2025 it generated -$87.8M of operating cash flow. As of 2026-06-30, cash was $16.3M against $93.9M of debt.
- Cash
- $16.3M
- Debt
- $93.9M
- Equity
- $43.6M
- Total assets
- $170.3M
- Shares outstanding
- 358,035,247
Quarterly, last 8 quarters
| Quarter | Period end | Revenue | Net income | Margin | Diluted EPS |
|---|---|---|---|---|---|
| Q2 FY 2026 | 2026-06-30 | $55.0M | $20.1M | 36.5% | 0.05 |
| Q1 FY 2026 | 2026-03-31 | $23.3M | -$7.9M | -34.1% | -0.02 |
| Q4 FY 2025derived | 2025-12-31 | n/a | -$23.5M | n/a | n/a |
| Q3 FY 2025 | 2025-09-30 | n/a | -$146.3M | n/a | -1.06 |
| Q2 FY 2025 | 2025-06-30 | $856K | -$26.6M | -3112.4% | -0.09 |
| Q1 FY 2025 | 2025-03-31 | $1.3M | -$54.2M | -4038.3% | -0.18 |
| Q4 FY 2024derived | 2024-12-31 | n/a | -$19.7M | n/a | n/a |
| Q3 FY 2024 | 2024-09-30 | n/a | -$24.0M | n/a | -0.09 |
Fiscal years, with buybacks and dividends
| Fiscal year | Ends | Revenue | Net income | Operating cash flow | Capex | Buybacks | Dividends |
|---|---|---|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $9.7M | -$250.6M | -$87.8M | $2.0M | n/a | n/a |
| FY 2024 | 2024-12-31 | $3.9M | -$126.2M | -$68.2M | $8.6M | n/a | n/a |
| FY 2023 | 2023-12-31 | $6.2M | -$95.9M | -$66.9M | $1.5M | n/a | n/a |
| FY 2022 | 2022-12-31 | $26.9M | $28.3M | -$65.0M | $4.9M | n/a | n/a |
| FY 2021 | 2021-12-31 | $14.3M | -$92.2M | -$55.8M | $7.2M | n/a | n/a |
Quarters are the three-month figures the company reports; a fourth quarter marked derived is the fiscal year less the three reported quarters, since companies report it only inside the 10-K. Fiscal years are the annual figures. Buybacks are the cash the company paid to repurchase its common stock in the year, not the amount authorized. Balance sheet lines are as of 2026-06-30; shares outstanding as of 2026-07-31 from the cover page.
What this page is
Precigen in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.
This page follows Precigen (PGEN), SEC CIK 1356090, listed on Nasdaq, classified by the SEC as pharmaceutical preparations. The cross-market tables live on the short interest and insider transactions hubs.
Source and updates
- Short interest
- FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-10-15.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-11-02.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-09-30.JSON and CSV
- Planned sales
- SEC EDGAR Form 144Source: SEC.New notices appear shortly after the SEC posts them; a notice is filed on or before the sale. Latest 2026-08-25.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-08-07.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Financials
- SEC EDGAR 10-K and 10-Q filingsSource: SEC.Weekly; values are as filed in the 10-Q and 10-K. Latest 2026-06-30.JSON and CSV
- Earnings dates
- SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-08-04.JSON and CSV
- Insider trades
- SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-09-23.JSON and CSV
- Company record
- EDGAR filing index for CIK 1356090Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 10 requests a minute without a key, 30 with a free key from a free account.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other companies the SEC classifies as pharmaceutical preparations
Other company pages
- STESTERIS
- STLDSteel Dynamics
- STRCStrategy
- STRLSterling Infrastructure
- STTState Street
- STXSeagate Technology Holdings
- STZConstellation Brands
- SUISun Communities
- SUNBSunbelt Rentals Holdings
- SWSmurfit Westrock
- SWKStanley Black & Decker
- SWKSSkyworks Solutions
- SXTCChina SXT Pharmaceuticals
- SYFSynchrony Financial
- SYKStryker
- SYNASynaptics
Datasets
Frequently Asked Questions
How much of PGEN is sold short?
46,390,144 shares were held short at the 2026-10-15 settlement, 10.2 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.
What is PGEN's daily short volume?
On 2026-11-02, 5,240,359 of the 8,042,074 PGEN shares reported to FINRA were sold short, 65.2% of the day's reported volume. Short volume is a flow for one day, not a position.
Does PGEN have fails to deliver?
The SEC's latest file shows 309 PGEN shares failed to deliver at settlement 2026-09-30. Fails are reported per settlement date and published twice a month with a lag.
Are PGEN insiders buying or selling?
Over the last 90 days PGEN insiders reported 1 open-market buy ($25K) against 5 sells ($2.6M), so the dollar flow leans toward selling. Latest filing: Thomasian Harry Jr. (Chief Financial Officer) on 2026-09-23.
Have PGEN insiders filed to sell?
18 Form 144 notices on file for PGEN worth $70.4M at the prices reported; 4 in the last 90 days worth $1.2M. Latest: Shah Rutul R filed on 2026-08-25 to sell 15,342 shares ($115K) from 2026-08-25.
Who owns 5% or more of PGEN?
6 holders report 5% or more of PGEN in their latest filing, 3 on Schedule 13D (active intent). The largest reported stake is RANDAL J. KIRK at 35.9% of the class (133,956,416 shares), filed 2026-03-31 for an event on 2026-03-30.
What did PGEN report last quarter?
In Q2 FY 2026 (quarter ended 2026-06-30) Precigen reported revenue of $55.0M, up 6322.7% from the same quarter a year earlier, and net income of $20.1M (0.05 diluted EPS). In FY 2025 it generated -$87.8M of operating cash flow. As of 2026-06-30, cash was $16.3M against $93.9M of debt.
Which tracked 13F managers own PGEN?
6 of the 30 tracked 13F managers held PGEN shares at their latest filing, $17.5M in all. The largest: Steve Cohen's Point72 Asset Management (1.3M shares, $7.2M), Ken Griffin's Citadel Advisors (820K shares, $4.7M), Renaissance Technologies (605K shares, $3.5M), Cliff Asness's AQR Capital Management (146K shares, $830K), Two Sigma Investments (137K shares, $781K), Izzy Englander's Millennium Management (101K shares, $575K).
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.